These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 846053)

  • 1. [Plasma renin activity in patients with essential hypertension].
    Feltynowski T
    Kardiol Pol; 1977; 20(1):23-34. PubMed ID: 846053
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in plasma renin activity of patients with essential hypertension induced by NaCl and by salt depletion.
    Kiprov D; Somova L; Pukhlev A; Dochev D
    Cor Vasa; 1970; 12(3):188-92. PubMed ID: 5488728
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasma renin activity and plasma aldosterone in essential hypertension: effect of age and diastolic blood pressure].
    Vetter H; Alasso I; Appenheimer M; Weiand H; Stelkens H; Lucas R; Glänzer K; Witassek F; Stumpe KO; Trübestein G; Krück F
    Schweiz Med Wochenschr; 1976 Dec; 106(49):1729-32. PubMed ID: 1013695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin subgroups in essential hypertension. Further analysis of their pathophysiological and epidemiological characteristics.
    Brunner HR; Sealey JE; Laragh JH
    Circ Res; 1973 May; 32():Suppl 1:99-105. PubMed ID: 4712516
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intra-erythrocytic sodium and plasma renin activity in primary arterial hypertension before and after furosemide therapy].
    Urbański K
    Pol Tyg Lek; 1983 Jul; 38(27):843-7. PubMed ID: 6361711
    [No Abstract]   [Full Text] [Related]  

  • 6. [Longitudinal studies in essential hypertensive patients with low plasma renin activity].
    Esch I; Placheta P; Gaul G; Kneussel K
    Wien Klin Wochenschr; 1973 Sep; 85(38):617-21. PubMed ID: 4752255
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of furosemide on plasma renin and aldosterone in three subtypes of essential hypertension.
    Cugini P; Serdoz R; Manconi R; Mancini A; Meucci T
    Boll Soc Ital Biol Sper; 1978 Jan; 54(2):111-5. PubMed ID: 737057
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma renin activity in hypertensive diseases.
    Itasaka Y
    Nagoya J Med Sci; 1970 Jul; 33(1):31-45. PubMed ID: 5453994
    [No Abstract]   [Full Text] [Related]  

  • 9. [Plasma renin and concentrations of sodium and potassium in plasma, erythrocytes and in the renal artery wall of patients with arterial hypertension].
    Andrenko PT; Sheverda MG
    Vrach Delo; 1971 Apr; 7():49-51. PubMed ID: 5140131
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasma renin activity in arterial hypertension].
    Woźniak K; Janicka L; Szczepański L; Tomaszewski J
    Ann Univ Mariae Curie Sklodowska Med; 1969; 24():143-52. PubMed ID: 5406024
    [No Abstract]   [Full Text] [Related]  

  • 11. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlations between plasma renin activity and blood pressure, erythrocyte count, hemoglobin, hematocrit as well as sodium, potassium, urea and creatinine in serum of hypertensive patients].
    Werning C; Stiel W; Schweikert HU; Stiel D; Vetter W; Siegenthaler W
    Z Klin Chem Klin Biochem; 1971 Jan; 9(1):13-7. PubMed ID: 4325297
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of furosemide stimulation on renin secretion and its application in examining activity of the renin-angiotensin system.
    Zofková I
    Cor Vasa; 1976; 18(4):304-9. PubMed ID: 1022409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differentiation of essential arterial hypertension by determination of plasma renin activity].
    Olmer AM; Salvadori JM; Paulin R; Martin-Laval C; Bourdais A
    Helv Chir Acta; 1975 Jun; 42(3):357-65. PubMed ID: 1158757
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sodium outflow rate through lymphocyte cell membranes, serum levels of sodium, potassium, aldosterone, total catecholamines, 6-keto- PGF2alpha and plasma renin activity in patients with primary arterial hypertension treated with captopril].
    Mazurek W; Halawa B; Borejko-Słopecka G
    Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):588-93. PubMed ID: 1488334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Catecholamines, prostaglandins and intracellular electrolyte levels in patients with hypertension and low plasma renin activity].
    Wocial B; Jabłońska-Skwiecińska E; Chodakowska J; Feltynowski T; Ignatowska-Switalska H; Pawłowski W; Chojnowski K; Januszewicz W
    Kardiol Pol; 1987; 30(9):545-54. PubMed ID: 3320452
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma renin activity in panhypopituitarism. Responses to sodium restriction, furosemide and corticotrophin administration.
    Murakami M; Takeda R; Morimoto S; Hirasawa K; Uchida K
    Acta Endocrinol (Copenh); 1972 Mar; 69(3):531-41. PubMed ID: 4111287
    [No Abstract]   [Full Text] [Related]  

  • 18. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urinary electrolyte excretion and plasma corticoid level at the furosemide administration test in low renin hypertension].
    Nigawara K; Kogawa T; Inazumi S; Yagihashi Y; Suzuki T; Funyu T; Kawamata A; Tulachan Y; Kudo T; Terayama Y
    Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):385-98. PubMed ID: 6750183
    [No Abstract]   [Full Text] [Related]  

  • 20. [Total plasma angiotensinase activity in essential hypertension].
    Heimgartner M; Corti R; Hodler M; Hodler J
    Schweiz Med Wochenschr; 1973 Mar; 103(13):485-91. PubMed ID: 4349241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.